We found that PD-1 blockade remarkably reduced CD11b+Gr1+ MDSCs in spleen, lymph node, blood as well as in tumor as compared with the vehicle only and wild-type syngeneic mice (Fig. 4A and Fig. S7A). This evidence concerns the gene ITGAM and neoplasm.